Wolverine Asset Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History
Bought
Maintained
Sold
Other funds holding OCDX
CG
VI
SCM
MF
Wolverine Asset Management's OCDX Position: Q1 2022 in Review
Wolverine Asset Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q1 2022, closing a stake of 1,000 shares — an estimated $21K sold.
Wolverine Asset Management first reported a position in OCDX in Q4 2021 and held it in 1 quarter. The position peaked at $21K in Q4 2021. 170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.
- Wolverine Asset Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
- Wolverine Asset Management sold 1,000 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q1 2022, an estimated $21K.
- Wolverine Asset Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 1 quarter.
- Wolverine Asset Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $21K in Q4 2021.
- 170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.
Based on Wolverine Asset Management's 13F filing for Q1 2022, filed 4 May 2022.